KZR Kezar Life Sciences, Inc.
Healthcare$7.29+0.00%ClosedMarket Cap: $53.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.82
P/S
0.00
EV/EBITDA
0.28
DCF Value
$9.69
FCF Yield
-78.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-58.4%
ROA
-66.5%
ROIC
-63.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-7.4M | $-5.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-8.3M | $-14.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-52.3M | $-56.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-11.7M | $-11.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.6M | $-13.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-17.6M | $-16.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-21.6M | $-20.2M | $— | — |
| FY null | $0.00 | NaN% | $-90.6M | $-83.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-21.9M | $-20.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-23.4M | $-21.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-23.7M | $-21.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-28.4M | $-32.3M | $-0.44 | — |